Allergen-avoidance measures in homes of house-dust-mite-allergic asthmatic patients: Effects of acaricides and mattress encasings

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 52, Issue 9, 1997, Pages 921-927

  Van Der Heide, S ^a   Kauffman, H F ^a   Dubois, A E J ^a   De Monchy, J G R ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Acaricides; Airway hyperresponsiveness; Allergen avoidance; Asthma; House dust mites; Mattress encasings

Indexed keywords

ACARICIDE; ALLERGEN; BENZYL BENZOATE;

AIRWAY PRESSURE; ALLERGIC REACTION; ARTICLE; ASTHMA; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HOUSE DUST; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MITE; PRIORITY JOURNAL; SPIROMETRY; STATISTICAL ANALYSIS;

EID: 0030826104     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1997.tb01252.x     Document Type: Article

References (26)

1. Gelber LE, Seltzer LH, Bouzoukis JK, Pollart SM, Chapman MD, Platts-Mills TAE. Sensitization and exposure to indoor allergens as risk factors for asthma among patients presenting to hospital. Am Rev Respir Dis 1993;147:573-8.
2. Peat JK, Tovey E, Toelle BG, et al. House dust mite allergens. A major risk factor for childhood asthma in Australia. Am J Respir Crit Care Med 1996;153:141-6.
3. Kerrebijn KF. Endogenous factors in childhood CNSLD: methodological aspects in population studies. In: Orie NGM, van der Lende R, editors. Bronchitis III. Proceedings of the Third International Symposium on Bronchitis, The Netherlands, 1969. Assen: Royal Van Gorcum, 1970:38-48.
4. Platts-Mills TAE, Thomas WR, Aalberse RC, Vervloet D, Chapman MD. Dust mite allergens and asthma: report of a second international workshop. J Allergy Clin Immunol 1992;89:1046-60.
5. Colloff MJ, Ayres J, Carswell F, et al. The control of allergens of dust mites and domestic pets: a position paper. Clin Exp Allergy 1992;22 Suppl 2:1-28.
6. Bessot JC, De Blay F, Pauli G. From allergen sources to reduction of allergen exposure. Eur Respir J 1994;7:392-7.
7. Chapman MD, Heymann PW, Sporik RB, Platts-Mills TAE. Monitoring allergen exposure in asthma: new treatment strategies. Allergy 1995;50 Suppl 25:29-33.
8. Kniest FM, Young E, van Praag MC, et al. Clinical evaluation of a double-blind dust-mite avoidance trial with mite-allergic rhinitic patients. Clin Exp Allergy 1991;21:39-47.
9. Ehnert B, Lau-Schadendorf S, Weber A, Buettner P, Schou C, Wahn U. Reducing domestic exposure to dust mite allergen reduces bronchial hyperreactivity in sensitive children with asthma. J Allergy Clin Immunol 1992;90: 135-8.
10. Dietemann A, Bessot JC, Hoyet C, Ott M, Verot A, Pauli G. A double-blind, placebo controlled trial of solidified benzyl benzoate applied in dwellings of asthmatic patients sensitive to mites: clinical efficacy and effect on mite allergens. J Allergy Clin Immunol 1993;91:738-46.
11. Marks GB, Tovey ER, Green W, Shearer M, Salome CM, Woolcock AJ. House dust mite allergen avoidance: a randomized controlled trial of surface chemical treatment and encasement of bedding. Clin Exp Allergy 1994;24: 1078-83.
12. Carswell F, Birmingham K, Oliver J, Crewes A, Weeks J. The respiratory effects of reduction of mite allergen in the bedrooms of asthmatic children - a double-blind controlled trial. Clin Exp Allergy 1996;26:386-96.
13. Owen SJ, Morganstern M, Hepworth J, Woodcock AA. Control of house dust mite antigen in bedding. Lancet 1990;335:396-7.
14. Wickman M, Nordvall SL, Pershagen G, Korsgaard J, Johansen N, Sundell J. Mite allergens during 18 months of intervention. Allergy 1994;49:114-19.
15. Weeks J, Oliver J, Birmingham K, Crewes A, Carswell F. A combined approach to reduce mite allergen in the bedroom. Clin Exp Allergy 1995;25:1179-83.
16. de Vries K, Goei JT, Booij-Noord H, Orie NOM. Changes during 24 hours in lung function and histamine hyperreactivity of the bronchial tree in asthmatic and chronic bronchitis patients. Int Arch Allergy Appl Immunol 1962; 20:93-101.
17. van der Heide S, De Monchy JGR, De Vries K, Bruggink TM, Kauffman HE Seasonal variation in airway hyperresponsiveness and natural exposure to house dust mite allergens in patients with asthma. J Allergy Clin Immunol 1994;93:470-5.
18. Niemeijer NR, Goedewaagen B, Kauffman HF, De Monchy JGR. Optimization of skin testing. I. Choosing allergen concentrations and cutoff values by factorial design. Allergy 1993;48:491-7.
19. Brand PL, Kerstjens HA, Jansen HM, Kauffman HF, De Monchy JGR. Interpretation of skin tests to house dust mite and relationship to other allergy parameters in patients with asthma and chronic obstructive pulmonary disease [Dutch CNSLD Study Group]. J Allergy Clin Immunol 1993;91:560-70.
20. Ridout S, Twiselton R, Matthews S, et al. Acarosan and the Acarex test in the control of house dust mite allergens in the home. Br J ClinTract 1993;47:141-4.
21. Kalra S, Crank P, Hepworth J, Pickering CA, Woodcock AA. Concentrations of the domestic house dust mite'allergen Der p I after treatment with solidified benzyl benzoate (Acarosan) or liquid nitrogen. Thorax 1993;48:10-13.
22. Huss RW, Huss K, Squire EN Jr, et al. Mite allergen control with acaricide fails. J Allergy Clin Immunol 1994;94:27-32.
23. Manjra A, Berman D, Toerinn A, Weinberg EG, Potter PC. The effects of a single treatment of an acaricide, Acarosan, and a detergent, Metsan, on Der p l allergen levels in the carpets and mattresses of asthmatic children. S Afr Med J 1994;84:278-80.
24. Marks GB, Tovey ER, Green W, Shearer M. The effect of changes in house dust mite allergen exposure on the severity of asthma. Clin Exp Allergy 1995;25:114-18.
25. Custovic A, Taggart SC, Francis HC, Chapman MD, Woodcock A. Exposure to house dust mite allergens and the clinical activity of asthma. J Allergy Clin Immunol 1996;98:64-72.
26. Bousquet J, Dhivert H, Michel FB. Current trends in the management of allergic diseases. Allergy 1994;49 Suppl 18:31-6.